+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Germany Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Hemp, Marijuana), Derivatives (CBD, THC, Others), End-use with Growth Forecasts, Key Companies and Competitive Analysis, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2025
  • Region: Germany
  • Grand View Research
  • ID: 5976474
The Germany Legal Cannabis Market was valued at USD 37.15 million in 2024, and is projected to reach USD 85.64 million by 2030, rising at a CAGR of 14.09%. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany.

Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in 2022.

Moreover, growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy.

In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany’s biggest annual gathering of influential political and cannabis business leaders.

The cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast period.

Germany Legal Cannabis Market Report Highlights

  • By source, the hemp segment dominated the market with the highest revenue share of 84.50% in 2024. Hemp covers an extensive range of products, including supplements, nutritional powders, beverages, protein & nutrition bars, animal feed, and pet food.
  • By derivatives, the CBD segment dominated the market with the largest revenue share of 63.61% in 2024. CBD is the non-psychoactive compound found in the cannabis plant, and its adoption is increasing for a wide range of health benefits.
  • By end use, the industrial use segment dominated the market with a revenue share of 80.26% in 2024.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. End Use outlook
2.3. Competitive Insights
Chapter 3. Germany Legal Cannabis Market Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Germany Legal Cannabis Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Germany Legal Cannabis: Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Current Market Trends in Cannabis Industry
3.5. Regulatory Scenario
3.6. Cannabis Consumption Pattern Analysis
3.7. Guidelines and Requirements for Cannabis Cultivation
3.8. Cannabis Facility Design and Equipment Requirements
3.9. Reimbursement Policies in the Germany
Chapter 4. Germany Legal Cannabis Market: Segment Analysis, By Source, 2018-2030 (USD Million)
4.1. Definition and Scope
4.2. Source Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Germany Legal Cannabis Market, by Source, 2018 to 2030
4.5. Marijuana
4.5.1. Marijuana Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Flower
4.5.2.1. Flower Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Hemp
4.6.1. Hemp Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.2. Hemp Oil
4.6.2.1. Hemp Oil Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6.3. Industrial Hemp
4.6.3.1. Industrial Hemp Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Germany Legal Cannabis Market: Segment Analysis, By Derivative, 2018-2030 (USD Million)
5.1. Definition and Scope
5.2. Derivative Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Germany Legal Cannabis Market, by Derivative, 2018 to 2030
5.5. CBD
5.5.1. CBD Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. THC
5.6.1. THC Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Germany Legal Cannabis Market: Segment Analysis, By End Use, 2018-2030 (USD Million)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Germany Legal Cannabis Market, by End Use, 2018 to 2030
6.5. Medical Use
6.5.1. Medical Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. Cancer
6.5.2.1. Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. Chronic Pain
6.5.3.1. Chronic Pain Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. Depression and Anxiety
6.5.4.1. Depression and Anxiety Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.5. Arthritis
6.5.5.1. Arthritis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.6. Diabetes
6.5.6.1. Diabetes Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.7. Glaucoma
6.5.7.1. Glaucoma Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.8. Migraines
6.5.8.1. Migraines Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.9. Epilepsy
6.5.9.1. Epilepsy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.10. Multiple Sclerosis
6.5.10.1. Multiple Sclerosis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.11. AIDS
6.5.11.1. AIDS Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.12. Amyotrophic Lateral Sclerosis
6.5.12.1. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.13. Alzheimers's
6.5.13.1. Alzheimers's Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.14. Post Traumatic Stress Disorder (PTSD)
6.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.15. Parkinson's
6.5.15.1. Parkinson's Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.16. Tourettes
6.5.16.1. Tourettes Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.17. Others
6.5.17.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Recreational Use
6.6.1. Recreational Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Industrial Use
6.7.1. Industrial Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Germany Legal Cannabis Market: Competitive Landscape
7.1. Participant’s Categorization
7.2. Company Market Position Analysis, 2024
7.3. Strategy Mapping
7.4. Company Profiles
7.4.1. The Cronos Group
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Organigram Holding, Inc.
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Tilray Brands
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Canopy Growth Corporation
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Aurora Cannabis
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. SynBiotic
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Cansativa GmbH
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. DEMECAN
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Four 20 Pharma
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Avextra Pharma GmbH
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Germany legal cannabis market, by source, 2018-2030 (USD Million)
Table 4 Germany legal cannabis market, by derivatives, 2018-2030 (USD Million)
Table 5 Germany legal cannabis market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Value-chain-based sizing & forecasting
Figure 5 QFD modeling for market share assessment
Figure 6 Market research approaches
Figure 7 Market formulation & validation
Figure 8 Germany legal cannabis market: market outlook
Figure 9 Germany legal cannabis competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook.
Figure 12 Industry value chain analysis
Figure 13 Germany legal cannabis market driver impact
Figure 14 Germany legal cannabis market restraint impact
Figure 15 Germany legal cannabis market strategic initiatives analysis
Figure 16 Germany legal cannabis market: Source movement analysis
Figure 17 Germany legal cannabis market: Source outlook and key takeaways
Figure 18 Hemp market estimates and forecasts, 2018-2030
Figure 19 Hemp Oil market estimates and forecasts, 2018-2030
Figure 20 Industrial Hemp market estimates and forecasts, 2018-2030
Figure 21 Marijuana market estimates and forecasts, 2018-2030
Figure 22 Flower market estimates and forecasts, 2018-2030
Figure 23 Oil and Tinctures market estimates and forecasts, 2018-2030
Figure 24 Germany legal cannabis market: Derivatives movement analysis
Figure 25 Germany legal cannabis market: Derivatives outlook and key takeaways
Figure 26 CBD market estimates and forecasts, 2018-2030
Figure 27 THC market estimates and forecasts, 2018-2030
Figure 28 Others market estimates and forecasts, 2018-2030
Figure 29 Germany legal cannabis market: End-use movement analysis
Figure 30 Germany legal cannabis market: End-use outlook and key takeaways
Figure 31 Industrial Use market estimates and forecasts, 2018-2030
Figure 32 Medical Use market estimates and forecasts, 2018-2030
Figure 33 Chronic Pain market estimates and forecasts, 2018-2030
Figure 34 Depression and Anxiety market estimates and forecasts, 2018-2030
Figure 35 Arthritis market estimates and forecasts, 2018-2030
Figure 36 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018-2030
Figure 37 Cancer market estimates and forecasts, 2018-2030
Figure 38 Migraines market estimates and forecasts, 2018-2030
Figure 39 Epilepsy market estimates and forecasts, 2018-2030
Figure 40 Alzheimers's market estimates and forecasts, 2018-2030
Figure 41 Multiple Sclerosis market estimates and forecasts, 2018-2030
Figure 42 AIDS market estimates and forecasts, 2018-2030
Figure 43 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018-2030
Figure 44 Tourettes market estimates and forecasts, 2018-2030
Figure 45 Diabetes market estimates and forecasts, 2018-2030
Figure 46 Parkinson's market estimates and forecasts, 2018-2030
Figure 47 Glaucoma market estimates and forecasts, 2018-2030
Figure 48 Others market estimates and forecasts, 2018-2030
Figure 49 Recreational Use market estimates and forecasts, 2018-2030
Figure 50 Key company categorization
Figure 51 Heatmap analysis, 2024

Companies Mentioned

The major companies featured in this Germany Legal Cannabis market report include:
  • The Cronos Group
  • Organigram Holding, Inc
  • Tilray Brands
  • Canopy Growth Corporation
  • Aurora Cannabis
  • SynBiotic
  • Cansativa GmbH
  • DEMECAN
  • Four 20 Pharma
  • Avextra Pharma GmbH

Table Information